admin

The randomized IMerge trial has shown that patients with lower-risk myelodysplastic syndromes (MDS) who relapsed or were refractory to standard treatment achieved improved rates of red blood cell (RBC) transfusion independence with an investigational telomerase inhibitor called imetelstat. This first-in-class drug demonstrated significantly higher rates of RBC transfusion independence for at least 8 weeks compared
0 Comments
The world’s largest experimental nuclear fusion reactor, the JT-60SA, was officially inaugurated in Japan on Friday, marking a significant step in the development of fusion technology. Unlike fission, which is currently used in nuclear power plants, fusion involves the fusion of two atomic nuclei, offering a potentially safer, more sustainable, and carbon-free source of energy.
0 Comments